Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 01 May 2026 for Solventum Corp. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Elizabeth Mily: trading record in brief
Elizabeth Mily (senior executive) discloses dealings in 2 companies, chiefly Bristol Myers Squibb Co and Solventum Corp. The record holds 7 filings, for trades running from 10 March 2022 to 30 April 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 1 May 2026, reports an option exercise in Solventum Corp. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Elizabeth Mily
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
3,403 shares0Common StockSEC:0001808438-26-000005:0
1,980 shares0Common StockSEC:0001808438-26-000003:0
3,564 shares0Common StockSEC:0001628280-25-025952:0
3,662 shares0Common Stock, $0.10 par valueSEC:0000014272-23-000098:0
4,005 shares0Common Stock, $0.10 par valueSEC:0000014272-23-000070:0
3,662 shares0Common Stock, $0.10 par valueSEC:0000014272-22-000103:0
4,005 shares0Common Stock, $0.10 par valueSEC:0000014272-22-000069:0
7 of 7 declarations
